JAM
SNOA icon

JW Asset Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

JW Asset Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-228
Closed -$60K – 19
2018
Q3 		$60K Hold
228
– – 0.03% 16
2018
Q2 		$102K Hold
228
– – 0.07% 19
2018
Q1 		$151K Hold
228
– – 0.15% 21
2017
Q4 		$223K Sell
228
-333
-59% -$285K 0.24% 21
2017
Q3 		$527K Hold
561
– – 0.39% 26
2017
Q2 		$668K Hold
561
– – 0.43% 26
2017
Q1 		$724K Buy
+561
New +$652K 0.15% 30

Other funds holding SNOA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return

JW Asset Management's SNOA Position: Q4 2018 in Review

JW Asset Management sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2018, closing a stake of 228 shares — an estimated $60K sold.

JW Asset Management first reported a position in SNOA in Q1 2017 and held it in 7 quarters. The position peaked at $724K in Q1 2017. 18 funds tracked by Wall St. Rank hold SNOA as of Q4 2018.

  • JW Asset Management reported no remaining Sonoma Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • JW Asset Management sold 228 Sonoma Pharmaceuticals shares in Q4 2018, an estimated $60K.
  • JW Asset Management first reported a position in Sonoma Pharmaceuticals in Q1 2017 and held it in 7 quarters.
  • JW Asset Management's Sonoma Pharmaceuticals position peaked at $724K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2018.

Based on JW Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.